ADC Therapeutics SA
Change company Symbol lookup
Select an option...
ADCT ADC Therapeutics SA
ALTR Altair Engineering Inc
CVX Chevron Corp
ASCB ASPAC II Acquisition Corp
STRS Stratus Properties Inc
ESMC Escalon Medical Corp
ATO Atmos Energy Corp
LVS Las Vegas Sands Corp
HUBB Hubbell Inc
PM Philip Morris International Inc
Go

Health Care : Biotechnology | Small Cap Blend
Based in Switzerland
Company profile

ADC Therapeutics SA is a Switzerland-based clinical-stage oncology drug discovery and development company. It develops antibody drug conjugates (ADCs) for the treatment of both solid and hematological cancers. It employs monoclonal antibodies specific to particular tumor antigens conjugated to a class of pyrrolobenzodiazepine (PBD)-based warheads to selectively target and kill cancer cells. The Company has multiple PBD-based ADCs in ongoing clinical trials, ranging from first in human to pivotal Phase II clinical trials, and numerous preclinical ADCs in development. Its main drug candidates are ADCT-301 for the treatment of lymphoma and leukemia and ADCT-402 for the treatment of non-Hodgkin’s lymphoma and B-cell leukemia. It serves customers in the United States, Switzerland, and the United Kingdom.

Closing Price
$4.82
Day's Change
-0.07 (-1.43%)
Bid
--
Ask
--
B/A Size
--
Day's High
5.16
Day's Low
4.82
Volume
(Light)
Volume:
176,916

10-day average volume:
231,023
176,916

Microsoft Corp. Stock Outperforms Market On Strong Trading Day

4:32 pm ET September 7, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Microsoft Corp. (MSFT) advanced 1.91% to $258.09 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.83% to 3,979.87 and the Dow Jones Industrial Average rising 1.40% to 31,581.28. The stock's rise snapped a seven-day losing streak. Microsoft Corp. closed $91.58 short of its 52-week high ($349.67), which the company achieved on November 22nd.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Apple Inc. (AAPL) rose 0.93% to $155.96, Alphabet Inc. Cl A (GOOGL) rose 2.47% to $109.45, and SAP SE ADR (SAP.XE) rose 1.66% to $85.57. Trading volume (22.8 M) remained 892,930 below its 50-day average volume of 23.7 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 7, 2022.

	

(END) Dow Jones Newswires

September 07, 2022 16:32 ET (20:32 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.